Pharmaceutical Lipid-Based Excipients Market Developments And Opportunities Across 2026–2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Pharmaceutical Lipid-Based Excipients Market Over The 2026–2030 Period?
The pharmaceutical lipid-based excipients market has exhibited robust growth over recent years. It is anticipated to increase from $1.77 billion in 2025 to $1.86 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. The expansion observed historically can be credited to the rising number of poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the growing utilization of oral delivery systems, and regulatory support for lipid excipients.
The pharmaceutical lipid-based excipients market size is expected to undergo robust expansion in the coming years. It is projected to achieve a valuation of $2.29 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is attributable to the increase in complex drug formulations, a surging demand for enhanced drug absorption, the expansion of biologics and oncology drugs, advancements in lipid technologies, and an escalating focus on patient-centric formulations. Significant trends for the forecast period include the increasing utilization of lipid excipients for drugs with poor solubility, their rising adoption in oral and parenteral formulations, a growing requirement for bioavailability-enhancing excipients, the broader development of lipid-based drug delivery systems, and a heightened emphasis on natural and sustainable lipids.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
What Primary Drivers Are Shaping The Pharmaceutical Lipid-Based Excipients Market?
The anticipated expansion of the pharmaceutical lipid-based excipients market is linked to the increasing prevalence of gene therapy. This medical approach focuses on altering or manipulating an individual’s genes to either cure or avert illnesses. Its growing prominence stems from progress in delivery mechanisms, which facilitate the secure, effective, and precise conveyance of genetic material into cellular structures. Pharmaceutical lipid-based excipients improve gene therapy’s efficacy by providing efficient delivery systems that ensure the stability and specific transport of genetic material. These excipients contribute to better therapeutic results through their role in safeguarding nucleic acids and aiding cellular absorption, thereby boosting the impact of contemporary treatments. As an illustration, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) granted approval to 6 gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expansion of gene therapy is a key factor propelling the pharmaceutical lipid-based excipients market forward.
How Is Segmentation Applied In The Pharmaceutical Lipid-Based Excipients Market Segment Analysis?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
What Emerging Trends Are Seen In The Pharmaceutical Lipid-Based Excipients Market?
Leading companies in the pharmaceutical lipid-based excipients market are prioritizing investments, such as strategic capital to establish advanced Centers of Excellence. These initiatives aim to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive stance in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, inaugurated a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s burgeoning pharma market by offering specialized laboratories and tailored support for excipient innovation, focusing on bioavailability, sustained release, and topical formulations, while simultaneously expanding its presence in the Asia-Pacific region. The sophisticated center features pharmaceutical and personal care application laboratories, fostering innovation, promoting collaboration, and providing a productive work environment.
Who Are The Companies Participating In The Pharmaceutical Lipid-Based Excipients Market Environment?
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth
Get The Full Pharmaceutical Lipid-Based Excipients Market Report:
Which Region Holds The Highest Market Share In The Pharmaceutical Lipid-Based Excipients Market?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pharmaceutical Lipid-Based Excipients Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Liposomal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
